1. Warttig S, Ward S, Rogers G. Guideline Development Group. 2014; Diagnosis and management of gallstone disease: summary of NICE guidance. BMJ. 349:g6241. DOI:
10.1136/bmj.g6241. PMID:
25360037.
Article
2. van Dijk AH, Wennmacker SZ, de Reuver PR, et al. 2019; Restrictive strategy versus usual care for cholecystectomy in patients with gallstones and abdominal pain (SECURE): a multicentre, randomised, parallel-arm, non-inferiority trial. Lancet. 393:2322–2330. DOI:
10.1016/S0140-6736(19)30941-9. PMID:
31036336.
Article
3. Manes G, Paspatis G, Aabakken L, et al. 2019; Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 51:472–491. DOI:
10.1055/a-0862-0346. PMID:
30943551.
Article
4. Maple JT, Ikenberry SO, et al. ASGE Standards of Practice Committee. 2011; The role of endoscopy in the management of choledocholithiasis. Gastrointest Endosc. 74:731–744. DOI:
10.1016/j.gie.2011.04.012. PMID:
21951472.
Article
6. Möller M, Gustafsson U, Rasmussen F, Persson G, Thorell A. 2014; Natural course vs interventions to clear common bile duct stones: data from the Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography (GallRiks). JAMA Surg. 149:1008–1013. DOI:
10.1001/jamasurg.2014.249. PMID:
25133326.
Article
8. Hakuta R, Hamada T, Nakai Y, et al. 2020; Natural history of asymptomatic bile duct stones and association of endoscopic treatment with clinical outcomes. J Gastroenterol. 55:78–85. DOI:
10.1007/s00535-019-01612-7. PMID:
31473828.
Article
9. Cox MR, Budge JP, Eslick GD. 2015; Timing and nature of presentation of unsuspected retained common bile duct stones after laparoscopic cholecystectomy: a retrospective study. Surg Endosc. 29:2033–2038. DOI:
10.1007/s00464-014-3907-x. PMID:
25398193.
Article
10. Collins C, Maguire D, Ireland A, Fitzgerald E, O'Sullivan GC. 2004; A prospective study of common bile duct calculi in patients undergoing laparoscopic cholecystectomy: natural history of choledocholithiasis revisited. Ann Surg. 239:28–33. DOI:
10.1097/01.sla.0000103069.00170.9c. PMID:
14685097. PMCID:
PMC1356189.
Article
11. Caddy GR, Kirby J, Kirk SJ, Allen MJ, Moorehead RJ, Tham TC. 2005; Natural history of asymptomatic bile duct stones at time of cholecystectomy. Ulster Med J. 74:108–112. PMID:
16235763. PMCID:
PMC2475382.
12. Dumonceau JM, Kapral C, Aabakken L, et al. 2020; ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 52:127–149. DOI:
10.1055/a-1075-4080. PMID:
31863440.
Article
13. Kim SB, Kim KH, Kim TN. 2016; Comparison of outcomes and complications of endoscopic common bile duct stone removal between asymptomatic and symptomatic patients. Dig Dis Sci. 61:1172–1177. DOI:
10.1007/s10620-015-3965-5. PMID:
26589817.
Article
14. Saito H, Kakuma T, Kadono Y, et al. 2017; Increased risk and severity of ERCP-related complications associated with asymptomatic common bile duct stones. Endosc Int Open. 5:E809–E817. DOI:
10.1055/s-0043-107615. PMID:
28879226. PMCID:
PMC5585073.
Article
15. Lee YS, Cho CM, Cho KB, et al. 2021; Difficult biliary cannulation from the perspective of post-endoscopic retrograde cholangiopancreatography pancreatitis: identifying the optimal timing for the rescue cannulation technique. Gut Liver. 15:459–465. DOI:
10.5009/gnl19304. PMID:
32000469. PMCID:
PMC8129666.
Article
16. Frossard JL, Hadengue A, Amouyal G, et al. 2000; Choledocholithiasis: a prospective study of spontaneous common bile duct stone migration. Gastrointest Endosc. 51:175–179. DOI:
10.1016/S0016-5107(00)70414-7. PMID:
10650260.
Article